CSNK1D Protein (Casein Kinase 1 Delta)

CSNK1D Protein (Casein Kinase 1 Delta)

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CSNK1D Protein (Casein Kinase 1 Delta)</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Casein Kinase 1 Delta</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>[CSNK1D](/genes/csnk1d)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P48730](https://www.uniprot.org/uniprot/P48730)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~55 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>494 aa</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q21.3</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Nucleus, Cytoskeleton</td>
</tr>
<tr>
<td class="label">Inhibitor</td>
<td>Specificity</td>
</tr>
<tr>
<td class="label">PF-670462</td>
<td>CK1δ/ε</td>
</tr>
<tr>
<td class="label">PF-4800567</td>
<td>CK1δ</td>
</tr>
<tr>
<td class="label">IC261</td>
<td>CK1δ/ε</td>
</tr>
<tr>
<td class="label">D4476</td>
<td>CK1 family</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[PER1](/genes/per1)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[PER2](/genes/per2)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[CLOCK](/genes/clock)</td>
<td>Complex</td>
</tr>
<tr>
<td class="l

CSNK1D Protein (Casein Kinase 1 Delta)

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CSNK1D Protein (Casein Kinase 1 Delta)</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Casein Kinase 1 Delta</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>[CSNK1D](/genes/csnk1d)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P48730](https://www.uniprot.org/uniprot/P48730)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~55 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>494 aa</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q21.3</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Nucleus, Cytoskeleton</td>
</tr>
<tr>
<td class="label">Inhibitor</td>
<td>Specificity</td>
</tr>
<tr>
<td class="label">PF-670462</td>
<td>CK1δ/ε</td>
</tr>
<tr>
<td class="label">PF-4800567</td>
<td>CK1δ</td>
</tr>
<tr>
<td class="label">IC261</td>
<td>CK1δ/ε</td>
</tr>
<tr>
<td class="label">D4476</td>
<td>CK1 family</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[PER1](/genes/per1)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[PER2](/genes/per2)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[CLOCK](/genes/clock)</td>
<td>Complex</td>
</tr>
<tr>
<td class="label">[BMAL1](/genes/arntl)</td>
<td>Complex</td>
</tr>
<tr>
<td class="label">[MAPT](/genes/mapt)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[SNCA](/genes/snca)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[HTT](/genes/htt)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[DVL1](/genes/dvl1)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[TP53](/genes/tp53)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">20 edges</a></td>
</tr>
</table>

Casein Kinase 1 Delta (CSNK1D) is a serine/threonine protein kinase that plays essential roles in circadian rhythm regulation, Wnt signaling, DNA damage response, and neuronal signaling pathways. CSNK1D is a member of the casein kinase 1 (CK1) family, which consists of seven isoforms (CK1α, CK1β, CK1γ1-3, CK1δ, CK1ε) with distinct subcellular localizations and functions. CK1δ is particularly important in neurodegeneration, as it phosphorylates key proteins implicated in Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD) [@neuro2019].

[@fasps1999]

Overview

CSNK1D encodes casein kinase 1 delta (CK1δ), a serine/threonine protein kinase that participates in various molecular pathways relevant to [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [Huntington's disease](/diseases/huntingtons), and related neurodegenerative conditions. CK1δ is a central regulator of circadian rhythm, phosphorylating core clock proteins, and is implicated in tau hyperphosphorylation, α-synuclein phosphorylation, and neuronal survival pathways.

Enzyme Structure and Activity

CK1δ is a 494-amino acid protein kinase with the following structural features:

Catalytic Domain (1-300 aa)

• Kinase domain: Contains the ATP binding site and catalytic core
• Activation loop: Regulates kinase activity through phosphorylation
• Substrate binding pocket: Recognizes specific phosphorylation motifs

Regulatory Domain (300-494 aa)

• C-terminal tail: Contains autophosphorylation sites that regulate activity
• Dimerization interface: Enables dimer formation for regulatory function
• Nuclear localization signals: Directs nuclear import

Catalytic Properties

CK1δ phosphorylates substrates with the consensus sequence:
Ser/Thr - X - X - Ser/Thr (where X is any amino acid)

Key characteristics:

• Pre-phosphorylated serine/threonine residues enhance substrate affinity
• Multiple phosphorylation sites create "phosphorylation clusters"
• Substrate specificity determined by surrounding sequence context
• Autophosphorylation at C-terminal tail enhances kinase activity

Biological Functions

Circadian Rhythm Regulation

CK1δ is a core component of the [circadian clock](/mechanisms/circadian-rhythm), working alongside CK1ε to phosphorylate core clock proteins [@fasps1999]:

PERIOD Protein Phosphorylation

Clock Mechanism

The circadian clock consists of transcription-translation feedback loops:

• BMAL1/CLOCK: Activator complex driving transcription of PER and CRY genes
• PER/CRY: Repressor complex that accumulates and inhibits their own expression
• CK1δ/CK1ε: Rate-limiting kinases controlling PER protein stability and localization

Wnt Signaling

CK1δ modulates the [Wnt/β-catenin pathway](/mechanisms/wnt-signaling) [@wnt2022]:

• Dishevelled phosphorylation: CK1δ phosphorylates Dvl, activating upstream Wnt signaling
• β-catenin degradation: Modifies the destruction complex activity
• Planar cell polarity: Regulates PCP pathway signaling
• Neuronal development: Controls axon guidance, dendrite morphogenesis, and synaptic formation

DNA Damage Response

CK1δ participates in [DNA damage response](/mechanisms/dna-repair-neurodegeneration) pathways [@ddr2023]:

• p53 phosphorylation: CK1δ phosphorylates p53 at multiple sites, activating tumor suppressor function
• MDC1 phosphorylation: Facilitates DNA damage response signaling
• Chk1 modulation: Affects cell cycle checkpoint activation
• Telomere maintenance: Regulates telomere length and function

Neuronal Signaling

CK1δ regulates numerous neuronal processes:

• Synaptic plasticity: Modulates AMPA and NMDA receptor trafficking
• Dopaminergic signaling: Affects dopamine transporter function
• Axonal transport: Phosphorylates transport regulatory proteins
• Dendritic spine morphology: Controls synaptic structure

Disease Associations

Familial Advanced Sleep Phase Syndrome (FASPS)

CK1δ mutations cause FASPS [@fasps1999]:

• T44A mutation: Reduced CK1δ activity, advanced sleep phase
• Short circadian period: ~20 hours instead of 24 hours
• Early bedtime and wake time: Characteristic sleep pattern
• Autosomal dominant inheritance: Familial cases reported

Huntington's Disease

CK1δ is a therapeutic target in HD [@hd2011]:

• CK1δ activity increased: In HD models and patient brains
• Mutant huntingtin phosphorylation: CK1δ phosphorylates mHtt at specific sites
• Toxicity modulation: CK1δ activity influences mHtt toxicity
• Therapeutic inhibition: CK1δ inhibitors reduce toxicity in models

Alzheimer's Disease

CK1δ contributes to AD pathogenesis [@ad2020]:

• Tau hyperphosphorylation: CK1δ phosphorylates tau at multiple sites (Ser202, Thr205, Ser396, Ser404)
• Neurofibrillary tangle formation: Hyperphosphorylated tau aggregates into NFTs
• Amyloid processing: Affects APP cleavage and Aβ production
• Circadian disruption: Contributes to sleep-wake cycle abnormalities

Parkinson's Disease

CK1δ is implicated in PD pathology [@pd2021]:

• α-Synuclein phosphorylation: CK1δ phosphorylates α-syn at S129
• Lewy body formation: Phosphorylated α-syn in Lewy bodies
• Dopaminergic dysfunction: Alters dopamine signaling and survival
• Circadian abnormalities: PD patients show disrupted circadian rhythms

Other Neurodegenerative Conditions

• Migraine: CK1δ variants associated with periodic limb movements
• Sleep disorders: Circadian rhythm dysfunction
• Amyotrophic lateral sclerosis: Potential role in TDP-43 pathology

Neurodegeneration Mechanisms

Tau Pathology

CK1δ is a major tau kinase implicated in [tauopathies](/mechanisms/tau-pathology) [@tau2004]:

Phosphorylation Sites

• Ser202/Thr205: Early phosphorylation sites in NFT formation
• Thr231: Critical site affecting microtubule binding
• Ser396/Ser404: Late-stage phosphorylation in mature NFTs

Pathological Effects

• Hyperphosphorylation: Contributes to neurofibrillary tangle formation
• Microtubule dissociation: Phosphorylated tau loses microtubule binding
• Aggregation propensity: Phosphorylation promotes fibril formation
• Spread and propagation: Phosphorylation affects tau seeding activity

Protein Aggregation

CK1δ affects aggregation pathways in multiple neurodegenerative diseases:

• α-Synuclein phosphorylation: S129 phosphorylation in Lewy bodies [@pd2021]
• TDP-43 pathology: Modulates TDP-43 aggregation in ALS/FTD
• Autophagy regulation: Phosphorylates autophagy regulatory proteins

Circadian Dysfunction

Altered circadian function contributes to neurodegeneration [@circadian2019]:

• Sleep-wake abnormalities: Common in AD, PD, and HD
• Metabolic dysregulation: Altered cellular metabolism
• Oxidative stress: Circadian-regulated antioxidant pathways disrupted
• Inflammation: Circadian control of immune function impaired

Therapeutic Implications

CK1δ Inhibitors

Several CK1δ inhibitors are in development [@inhibitors2020]:

Drug Development Strategies

• Blood-brain barrier penetration: Critical for CNS therapies
• Isoform selectivity: Target CK1δ over other isoforms
• Timing optimization: Circadian-appropriate dosing may enhance efficacy
• Combination therapy: Combined with disease-modifying agents

Interacting Proteins

Research Models

Animal Models

• CSNK1D knockout mice: Viable with subtle circadian and developmental defects
• Transgenic models: Overexpression of wild-type and mutant forms
• Knock-in models: Human FASPS mutations introduced
• HD models: CK1δ modulation in R6/2 and other models

Cell Culture

• Primary neurons: Study neuronal CK1δ function
• Circadian cell lines: PER2-luc reporter cells for rhythm studies
• Patient-derived cells: iPSC models of neurodegeneration
• HEK293 and SH-SY5Y: Expression and biochemical studies

Summary

CSNK1D encodes casein kinase 1 delta, a serine/threonine kinase critical for circadian rhythm regulation, Wnt signaling, DNA damage response, and neuronal function. CK1δ phosphorylates core clock proteins (PER1, PER2), tau, α-synuclein, and huntingtin, linking circadian dysfunction to neurodegenerative pathologies. Mutations cause familial advanced sleep phase syndrome, while dysregulation contributes to Alzheimer's disease, Parkinson's disease, and Huntington's disease. CK1δ inhibitors represent potential therapeutic agents for multiple tauopathies and proteinopathies.

Background

The study of CSNK1D has evolved significantly over the past two decades:

• 1999: First CK1δ mutation identified in FASPS patients
• 2004: CK1δ identified as major tau kinase
• 2011: CK1δ validated as therapeutic target in HD
• 2019-2020: Multiple CK1δ inhibitors in preclinical development

See Also

• [CSNK1D Gene](/genes/csnk1d)
• [CSNK1E Gene](/genes/csnk1e)
• [Tau Pathology](/mechanisms/tau-pathology)
• [Circadian Rhythm](/mechanisms/circadian-rhythm)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntingtons)
• [Wnt Signaling](/mechanisms/wnt-signaling)
• [DNA Damage Response](/mechanisms/dna-repair-neurodegeneration)

External Links

• [UniProt P48730](https://www.uniprot.org/uniprot/P48730) - Protein sequence and structure
• [NCBI Gene CSNK1D](https://www.ncbi.nlm.nih.gov/gene/1455) - Gene database
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature

References